Tepper, principal investigator for phase 3 trials of Symbravo as acute treatment for migraine in adults, reviews the new drug's dual MOA and target patient populations.
Stewart Tepper, MD
Advertisement
Articles by Stewart Tepper, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
Menopause Education Wholly Inadequate for Physician Associates, According to New Survey Results
2
Menopause Education Lags in Residency Training Across Primary Care Specialties
3
Timing of Menopausal Hormone Therapy May Impact Biomarkers of Alzheimer Disease
4
Menopause: A Constellation of Syndromes Across 13 Body Systems
5
